Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1996 1
2002 1
2004 2
2005 1
2009 2
2010 1
2011 1
2012 1
2013 2
2016 1
2017 2
2018 3
2019 3
2020 1
2021 2
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20AJ, 5BAuthor
Page 1
Imidazole-pyridine hybrids as potent anti-cancer agents.
Aruchamy B, Drago C, Russo V, Pitari GM, Ramani P, Aneesh TP, Benny S, Vishnu VR. Aruchamy B, et al. Eur J Pharm Sci. 2023 Jan 1;180:106323. doi: 10.1016/j.ejps.2022.106323. Epub 2022 Nov 4. Eur J Pharm Sci. 2023. PMID: 36336277 Free article.
In the current investigation, fifteen novel imidazole-pyridine-based molecules were synthesized and tested against cell lines of the lung (H1299) and colon (HCT116) adenocarcinomas by proliferation assay. The results demonstrated that compounds 5a, 5d, 5e, and 5f were the …
In the current investigation, fifteen novel imidazole-pyridine-based molecules were synthesized and tested against cell lines of the lung (H …
What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results.
Locatelli F, Messa P, Bellasi A, Cozzolino M, Di Luca M, Garibotto G, Gesualdo L, Malberti F, Massimetti C, Mazzaferro S, Mereu MC, Morosetti M, Morrone LF, Panuccio V, Rapisarda F, Russo D, Schinella D. Locatelli F, et al. G Ital Nefrol. 2013 Sep-Oct;30(5):gin/30.5.4. G Ital Nefrol. 2013. PMID: 24402624 Free article.
The EVOLVE Study was designed to test whether a drug such as cinacalcet, aimed at lowering iPTH, could reduce the astonishingly high cardiovascular risk in patients on maintenance dialysis (CKD-5D). Accordingly, the primary outcome of the study was the combined endpoint of …
The EVOLVE Study was designed to test whether a drug such as cinacalcet, aimed at lowering iPTH, could reduce the astonishingly high cardiov …
Patient-Reported Outcome Measures Used in Randomized Controlled Trials Following Surgical Intervention for Endometriosis: A Structured Review from the AAGL Practice Guidelines Group.
Abbott J, Billow M, Gallant T, Hackett L, Kho RM, Knapman B, Russo MAL, Maheux-Lacroix S, Gonzalez AM, Ng C, Orlando MS, Sit A, Xu X. Abbott J, et al. J Minim Invasive Gynecol. 2024 Feb;31(2):71-83.e17. doi: 10.1016/j.jmig.2023.10.017. Epub 2023 Nov 4. J Minim Invasive Gynecol. 2024. PMID: 37931893 Review.
The PROMs used by high-quality RCTs for QoL include Endometriosis Health Profile-30, Endometriosis Health Profile-5, Short-Form 36, Short-Form 12, and EQ-5D; for bowel-related symptoms Knowles-Eccersley-Scott-Symptom Questionnaire, Gastrointestinal Quality of Life Index, a …
The PROMs used by high-quality RCTs for QoL include Endometriosis Health Profile-30, Endometriosis Health Profile-5, Short-Form 36, Short-Fo …
Are We Agreed? Self- Versus Proxy-Reporting of Paediatric Health-Related Quality of Life (HRQoL) Using Generic Preference-Based Measures: A Systematic Review and Meta-Analysis.
Khanna D, Khadka J, Mpundu-Kaambwa C, Lay K, Russo R, Ratcliffe J; Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team. Khanna D, et al. Pharmacoeconomics. 2022 Nov;40(11):1043-1067. doi: 10.1007/s40273-022-01177-z. Epub 2022 Aug 23. Pharmacoeconomics. 2022. PMID: 35997957 Free PMC article.
Seven generic preference-based measures were identified as having been applied: Health Utilities Index (HUI) Mark 2 and 3, EQ-5D measures, Child Health Utility 9 Dimensions (CHU9D), and the Quality of Well-Being (QWB) scale. ...In contrast to more observable HRQoL domains …
Seven generic preference-based measures were identified as having been applied: Health Utilities Index (HUI) Mark 2 and 3, EQ-5D meas …
Long-Term Effects of Hospitalization for COVID-19 on Frailty and Quality of Life in Older Adults ≥80 Years.
Covino M, Russo A, Salini S, De Matteis G, Simeoni B, Pirone F, Massaro C, Recupero C, Landi F, Gasbarrini A, Franceschi F. Covino M, et al. J Clin Med. 2022 Sep 29;11(19):5787. doi: 10.3390/jcm11195787. J Clin Med. 2022. PMID: 36233655 Free PMC article.
Frailty was assessed by the clinical frailty scale (CFS), and the QOL was assessed by the five-level EuroQol EQ-5d tool. Multivariate Cox regression analyses and logistic regression analyses were used to identify independent factors for poor outcomes. ...
Frailty was assessed by the clinical frailty scale (CFS), and the QOL was assessed by the five-level EuroQol EQ-5d tool. Multivariate …
Association Between Levels of Functional Disability and Health-Related Quality of Life With Spinal Cord Stimulation for Chronic Pain.
Taylor RS, Soliday N, Leitner A, Hunter CW, Staats PS, Li S, Thomson S, Kallewaard JW, Russo M, Duarte RV. Taylor RS, et al. Neuromodulation. 2023 Jul;26(5):1039-1046. doi: 10.1016/j.neurom.2022.04.039. Epub 2022 May 26. Neuromodulation. 2023. PMID: 35643846
Patients reporting "minimum disability," "moderate disability," "severe disability," and "crippled" had mean EQ-5D scores of 0.82, 0.73, 0.59, and 0.45, respectively. The mean change in EQ-5D score was 0.007 per unit change in total ODI score. The R(2) statistic sho …
Patients reporting "minimum disability," "moderate disability," "severe disability," and "crippled" had mean EQ-5D scores of 0.82, 0. …
Durability of the Therapeutic Effect of Restorative Neurostimulation for Refractory Chronic Low Back Pain.
Mitchell B, Deckers K, De Smedt K, Russo M, Georgius P, Green M, Gulve A, van Buyten JP, Smet I, Mehta V, Baranidharan G, Rathmell J, Gilligan C, Goss B, Eldabe S. Mitchell B, et al. Neuromodulation. 2021 Aug;24(6):1024-1032. doi: 10.1111/ner.13477. Epub 2021 Jul 9. Neuromodulation. 2021. PMID: 34242440 Free PMC article.
Annual follow-up through four years included collection of NRS, ODI, and European Quality of Life Score on Five Dimensions (EQ-5D). Background on mechanisms, trial design, and one-year outcomes were previously described. RESULTS: At baseline (N = 53) (mean SD) age was 44 1 …
Annual follow-up through four years included collection of NRS, ODI, and European Quality of Life Score on Five Dimensions (EQ-5D). B …
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.
D'Angelo S, Tirri E, Giardino AM, Mattucci-Cerinic M, Dagna L, Santo L, Ciccia F, Frediani B, Govoni M, Bobbio Pallavicini F, Grembiale RD, Delle Sedie A, Mulè R, Cantatore FP, Foti R, Gremese E, Conigliaro P, Salaffi F, Viapiana O, Cauli A, Giacomelli R, Arcarese L, Guggino G, Russo R, Puenpatom A, Capocotta D, Nacci F, Anelli MG, Picerno V, Binetti C, Iannone F. D'Angelo S, et al. J Clin Med. 2022 Jul 19;11(14):4178. doi: 10.3390/jcm11144178. J Clin Med. 2022. PMID: 35887946 Free PMC article.
The primary objective was to evaluate the effectiveness of GLM after 6 months. Changes in quality of life using the EQ-5D-5L were also assessed. A total of 194 patients aged 53.2 12 years started GLM as a second anti-TNF drug: 39 (20.1%) with RA, 91 (46.9%) with PsA and 64 …
The primary objective was to evaluate the effectiveness of GLM after 6 months. Changes in quality of life using the EQ-5D-5L were als …
34 results